View Article

  • Argyreia Nervosa (Burm. F.) Bojer: Rediscovering A Traditional Healer Through The Prism of Modern Science—From Ethnomedicinal Wisdom to Evidence-Based Therapeutics

  • Department Of Pharmacognosy, Priyadarshini J.L. College of Pharmacy, Nagpur, Maharashtra

Abstract

Argyreia nervosa (Burm. f.) Bojer, commonly known as Vidhara or Hawaiian Baby Woodrose, is an important medicinal climber extensively used in traditional systems of medicine, particularly Ayurveda, for the management of neurological disorders, inflammation, reproductive ailments, metabolic disturbances, and wound healing. Owing to its wide ethnomedicinal relevance, considerable scientific investigations have been conducted to explore its pharmacognostic characteristics, phytochemical composition, and pharmacological potential. The present review aims to provide a comprehensive and updated compilation of available information on the plant, covering its botanical taxonomy, morphology, microscopic features, physicochemical standards, traditional uses, and phytoconstituents isolated from various plant parts. The review further summarizes extraction methods, preliminary phytochemical screening, quantitative estimation of major secondary metabolites, and reported pharmacological activities validated through experimental studies. Additionally, recent efforts toward pharmaceutical utilization, including the development and evaluation of topical formulations containing plant extracts, are discussed to highlight its translational therapeutic potential. By integrating classical knowledge with contemporary scientific findings, this review attempts to identify research gaps and future prospects for standardization, clinical validation, and formulation development of A. nervosa. The compiled data may serve as a valuable reference for researchers working in pharmacognosy, phytochemistry, and herbal drug development.

Keywords

Argyreia nervosa, Ethnopharmacology, Phytochemistry, Herbal formulations Quality control of herbal drugs, Bioactive secondary metabolites, Pharmaceutical evaluation, Natural product research.

Introduction

× Popup Image

Medicinal plants have long served as an essential resource for human health, offering a rich repertoire of bioactive compounds that predate modern pharmaceuticals. Traditional systems such as Ayurveda emphasize holistic well-being and the use of plant remedies to restore physiological balance, underscoring their enduring relevance in contemporary healthcare research [1,2]. There is growing scientific interest in validating ethnobotanical knowledge, driven by the need for multi-targeted agents with better safety profiles than many synthetic drugs [3,4].

Despite India’s rich botanical heritage, many traditionally used species lack comprehensive phytochemical and pharmacological documentation. A systematic understanding of these plants is crucial for bridging the gap between traditional claims and modern therapeutic applications [5].

A. nervosa is a very valuable plant in the Ayurvedic system. In 'Rasayan' drug it has been used for the treatment of various neurological diseases. It has been also reported in indigenous medicine system that A.nervosa has given for chronic gonorrhea, ulcer, severe pain in urinary bladder (strangury), gleets, male sexual disorder. The plant leaves also possess the therapeutic activity against several skin diseases such as eczema, itching, ringworm and systemically in skin abscess. In addition, it also used as a rubefacient and local skin stimulant. In Rajasthan, some tribal’s used leaves to prevent the conceived in females [6]. Its root taste is bitter and having the multiple uses like as a brain tonic, diuretic, aphrodisiac, rheumatism. In other hands for persistent cold & cough, and in resulting fever, root paste with Grewia hirsute, Asparagus racemosus and Hemidesmus indicus prescribed for immediate relief. Its seven times root powder is macerated throughout 7 days with tubers juice of Asparagus racemosus as nervine tonic. It promotes intellect, strengthens body and counteracts influences of age. In addition one of its preparation known as Ajmodadi Churna used for unilateral paralysis, dysentry and rheumatic ailments [7,8]. A.nervosa seed exhibited potential psychedelic, antihypertensive and spasmolytic activity. Seed consisted of the various neuropharmacological active constituents which are the isomer of lysergic acid diethylamide (LSD) such as lysergacidamide and lysergacidethylamide. Due to this reason, the seed has been the misuse of psychomotor agitation, an orientation of disturbances and anxiety.

GEOGRAPHICAL DISTRIBUTION

Argyreia nervosa, is widely distributed plant species in India. It is commonly known as Elephant creeper, Samundar ka pat and Vryddhadaru. It is found throughout in India up to altitude of 500 m. It is great climber with big ovate-cordate leaves found growing native in north-eastern Himalaya, Dehradun, Konkan, Rajasthan, Mysore, and Bengal [9]. A. speciosa usually appreciated for its aesthetic merit. It is grown as an ornamental and decorative plant because its leaves are heart shape, green color and flowers are look like rose purple [10]. 

BOTANICAL DESCRIPTION AND TAXONOMY

Argyreia nervosa (Burm. f.) Bojer is a perennial woody climber belonging to the family Convolvulaceae. The plant is characterized by large, heart-shaped leaves with dense silvery pubescence on the abaxial surface, long twining stems, and showy purple to violet funnel-shaped flowers. The seeds are globose to ovoid and covered with silky hairs. The plant thrives in tropical and subtropical climates and is widely distributed across India, Sri Lanka, and other parts of Southeast Asia [11,12].

Fig 1: Argyreia nervosa plant

BOTANICAL TAXONOMY (13,14) 

Rank

Classification

Kingdom

Plantae

Subkingdom

Tracheobionta

Division

Magnoliophyta

Class

Magnoliopsida

Order

Solanales

Family

Convolvulaceae

Genus

Argyreia

Species

Nervosa

Botanical name

Argyreia nervosa

Table 1: Taxonomical classification

Language

Vernacular name

English

Elephant creeper, Baby wood-rose, Elephant-climber, Elephant-creeper

Hindi

samandar-ka-pat, Samundarsokha, Ghav-patta, Bidhara

Marathi

Samudarsoka

Sanskrit

Vridhadaraka

Bengali

Bijarka

Gujrati

Samudarsoka

Unani

Samudarsoka

Tamil

Sadarpalai, Samuddirapacchai

Telegu

Chandrapada

Nepali

Samudraphool

Table 2: Vernacular names

ETHANOPHARMACOLOGICAL USES

Whole plant: It is used for stomach issues, foot sores, small pox, syphilis, dysentery and diarrhoea, antifertility, anti-rheumatic, and antifungal, they are all covered. In vasectomies, it is also utilised during recanalization [15]

  1. Leaf: The leaves are extensively used all over India for the treatment of ulcers, boils, carbuncles and tumours. The leaf is collected in the folded stage before opening and used freshly in Maharashtra; elsewhere the mature leaves are used. When leaf is applied with the ventral surface in contact with the body and bandaged, the boil, carbuncle or tumour regress and disappear. Antiphlogistic, emollient, poultices of wounds, externally for skin disease, gleet, gonorrhoea and chronic ulcers. Also used as a local stimulant and rubefacient. It is also externally used for ring worm infections and eczema. It is mixed with vinegar and the sap is rubbed to reduce obesity. The leaves contain a mixture of three phytosterolins which exhibit hypoglycemic and CNS depressant activities. The leaves are reported to be effective in diabetes Eczema, itch and other skin disease. Fresh leaves ponded into a lump and taken during empty stomach for three consecutive days from 4th day of menstruation and repeated for three successive months to avoid conception for a few years.

Fig 2: A.nervosa leaf

  1. Root: The root is aphrodisiac, nervine, alterative, diuretic, tonic, antigonorrheic, intellect-promoting, thermogenic, sweet, alterative, emollient, digestive, aperient, purgative, carminative, aphrodisiac, nervine, alterative, emollient, anti-inflammatory, and antirheumatic. Anorexia, loss of appetite, dyspepsia, flatulence, colic, chronic ulcer, ascites, haemorrhoids, hemiplegia, nerve weakness, neuralgic symptoms, brain problems, synovitis, and general weakness might all benefit from it. Roots have a cardiotonic effect and are therefore helpful for heart debility. It is used to treat obesity since it has emaciation-inducing effects. Leucorrhoea, diabetes mellitus, infected wounds, syphilis, cough, bronchitis, pharyngitis, and pulmonary TB are other conditions for which it is recommended. In the Yunani medical system, the root is used to treat chronic ulcers, gleet, gonorrhoea, and stranguria. The powdered root is used with milk for synovitis [16].

Fig 3: A.nervosa roots

  1. Seeds: It has significant hypotensive and spasmolytic activity and is used to treat anorexia, diabetes, and a number of skin problems. Seed has spasmolytic and CVS (cardio-vascular system) activity. A fraction containing three alcohols, one of which being ergometrine, was the source of the hypotensive activity [17]. The seeds are used secretly as a hallucinogen. After eating seed, there have been reports of toxic psychosis including hallucinations, orientation problems, and psychomotor agitation and anxiety. The presence of alkaloids, including lysergacidamide, lysergacidethylamide, and their structurally related isomers led to the (psycho) pharmaceutical effect (LSD). It produced psychic effects that were considerably dissimilar from those of LSD but resembled those of scopolamine [18].

Fig 4: A.nervosa seeds

Plant Part

Traditional Uses

Mode of Application

Reported Region/System

Root

Aphrodisiac, tonic, anti-inflammatory, nervine, rejuvenator

Decoction, powder, tonic

Ayurveda,

Folk medicine

Leaves

Wound healing, skin infections, inflammation

Paste/poultice (topical)

Folk medicine

Seeds

Nervine tonic, aphrodisiac, psychoactive uses

Powder/decoction

Traditional, ethnobotanical uses

Stem

Anti-inflammatory, pain relief

Decoction

Folk medicine

 

 

 

 

Whole plant

General tonic, fever management

Decoction

Folk medicine

Table 3: Compilation of Ethnopharmacological Uses (20)

MORPHOLOGY (21-26)

Convolvulaceae is the family to which Argyreia nervosa belongs. It is a climbing shrub with a woody tomentose stem. In English-speaking nations, it is frequently referred to as elephant creeper, while among Hindi-speaking Indians, it is called samundar-ka-pat. [21] It is widely found throughout the world's tropical regions. It is commonly grown natively in India, from Assam and Bengal to Karnataka, and has been observed up to 900 meters above sea level. [22,23] Typically, it grows as undergrowth in semidecidous forests and along riverbanks, lakeshores, and other slightly damp areas. [24] It is a twining, woody climber that can grow to a height of at least 10 meters. Simple, alternating leaves range in length from 5 to 15 cm. Large, showy, funnel-shaped flowers with a distinct odour and slightly bitter taste are borne on stout, whitish, and tomentose peduncles. The flowers are tinted purple or pale to deep rose and are regular, with short pedicels in axillary bracteates cymes. [25] The smooth, globose, indehiscent, irregularly crumbling berries have a diameter of 1.2–1.8 cm and are yellowish brown in color. They contain one or two seeds encased in a mealy pulp. The seeds are roughly triangular in shape, with two flat or slightly concave sides and a convex third. They range in length from 0.5 to 0.75 cm and width from 5 mm. When the stem is young, it is tomentose and white. The older stem (25 mm) is so thick that many lenticels, most of which are transversely elongated, are visible along with vertical ridges. Both in size and thickness, Argyreia nervosa roots vary in size. The thin roots have a smooth, brownish exterior and typically have a diameter of 2-4 mm. When they are cut transversely, a thin periderm and cambium can be seen, which appears as a dark line that divides the inner central wood from the outer phloem almost halfway between the two. Due to the abundance of lenticels, the thicker roots, which have a diameter of 5 to 25 mm or more, have a rough exterior. The plant is multiplied by seeds as well as stem cuttings. [26]

Plant Part

Morphological Characteristics

Root

Thick, cylindrical, woody roots used medicinally

Stem

Twining, woody climber, pubescent when young

Leaves

Large, cordate, velvety underside

Flowers

Purple/violet, funnel-shaped

Fruit

Globose capsule

Seeds

Hard, brown or black, ovoid

Table 4: Morphological Characteristics

MICROSCOPY

Microscopic evaluation of plant tissues is an essential component of pharmacognostic standardization. It aids in authenticating the drug, detecting adulteration, and establishing key diagnostic features for quality control (World Health Organization, 1998).

  1. Leaf Microscopy

Transverse Section (TS) of Leaf:

The TS of a mature A. nervosa leaf typically displays a dorsiventral structure with a well-defined vascular system. The lower epidermis shows a greater density of stomata than the upper surface, with paracytic stomata being commonly observed. Vascular bundles in the mesophyll are surrounded by a sheath of sclerenchyma fibers, and the presence of parenchymatous cells with chloroplasts is characteristic. Powder microscopy often reveals parenchyma cells, xylem vessels with pitted walls, and epidermal cells with anisocytic stomata (Balbir Singh, 2018; adapted from WHO recommended methods).

  1. Stem Microscopy

Transverse Section of Stem:

In young stems, the epidermis consists of a single layer of thick-walled cells often covered by a cuticle. Beneath this, the cortex is composed of parenchyma cells and occasional collateral vascular bundles. The vascular tissue consists of continuous rings of xylem and phloem with interspersed fibers. Under microscopic examination, fiber cells show lignified walls, and sclerenchymatous elements are observed around the vascular bundles. Powdered stem material may show cork cells, long fibers, and stone cells, which are useful diagnostic markers in drug identification (Balbir Singh, 2018).

  1. Root Microscopy

Transverse Section of Root:

Microscopic study of A. nervosa roots reveals distinct anatomical zones: the epidermis, cortex, and vascular tissues (xylem and phloem). The young root’s epidermis consists of small, cuboidal parenchyma cells, followed by a wide cortex. The primary vascular structure is typically tetrarch or pentarch in younger roots. In mature roots, a narrow periderm of cork cells is present, beneath which secondary phloem and secondary xylem predominate. The xylem contains large vessels with bordered pits, and the presence of rosette crystals of calcium oxalate in parenchymal cells.

  1. Root Microscopy

The detailed transverse section (TS) of the seed shows a tangentially elongated, oval to rectangular, single-layered epidermis of the testa. The epidermis bears thick-walled, mostly unicellular and occasionally bicellular, pointed, simple covering trichomes. Beneath the epidermis lies a layer of unequally high, radially elongated, thick-walled, lignified hypodermal cells containing yellowish-brown contents at the top. The hypodermis, a few rows of thick-walled, column-like palisade cells with a longitudinal central lumen are present. The cells of the first row are the longest in height and show a distinct crossing linea lucida at the top. Beneath the palisade layer, there are 5–7 rows of tangentially elongated, thin-walled parenchymatous cells embedded with a few round and oval, simple starch grains. (Sukumar, S., et.al)

  1. Powder Microscopy

Microscopic Features in Powdered Drug:

Powdered samples of A. nervosa leaf, stem, or root exhibit certain recognisable features:

  • Cork cells with thick walls
  • Xylem vessels with scalariform or circular pits
  • Fibers and sclerenchyma cells with lignified walls
  • Parenchymatous cells
  • Cluster crystals of calcium oxalate
  • Trichomes or cylindrical unicellular hairs (leaf/stem).

Plant Part

Diagnostic Microscopic Features

Leaf TS

Paracytic stomata; vascular bundles with sclerenchymatous sheath; parenchyma with chloroplasts

Stem TS

Thick-walled epidermal cells, lignified fibers, sclerenchyma around vascular bundles

Root TS

Cork layer, wide cortex, secondary xylem with bordered pits, calcium oxalate crystals

Powder

Cork cells, pitted xylem vessels, fibers, parenchyma, crystal aggregates

Table 5: Microscopic Diagnostic Features

Fig 5: Microscopy of roots (Ahlawat, S., et al. (2009)

Fig 6: Powder microscopy of A.nervosa (Balbir Singh. (2018)

Parameter

Observation / Value

Type

Significance

Reference

Stomatal Type

Anomocytic

Qualitative

Diagnostic feature of Convolvulaceae

Metcalfe & Chalk (1950)

Stomatal Index (Upper Epidermis)

4.5/mm²

Quantitative

Indicates low stomatal density on upper surface

Secondary compiled data

Stomatal Index (Lower Epidermis)

16/mm²

Quantitative

Confirms hypostomatic nature of leaf

Secondary compiled data

Stomatal Distribution

Lower > Upper epidermis

Qualitative

Typical dorsiventral leaf

Evans (2009)

Vein Islet Number

10.2/mm²

Quantitative

Important for leaf authentication

Secondary compiled data

Vein Termination Number

12.6/mm²

Quantitative

Species-specific diagnostic parameter

Secondary compiled data

Palisade Cells

Single-layered, elongated

Qualitative

Indicates dorsiventral anatomy

Nadkarni (2009)

Palisade Index

Not reported

Quantitative

Gap in pharmacognostic standardization

Trichomes

Multicellular, uniseriate covering hairs

Qualitative

Gives velvety texture; diagnostic

Warrier et al. (1993)

Epidermal Cells

Irregular, wavy walls

Qualitative

Typical dicot feature

Metcalfe & Chalk (1950)

Spongy Parenchyma

Loosely arranged

Qualitative

Facilitates gas exchange

Evans (2009)

Calcium Oxalate Crystals

Present

Qualitative

Microscopic diagnostic marker

Kokate et al. (2010)

Vascular Bundle

Collateral, closed

Qualitative

Typical dicot structure

Esau (1977)

Cuticle

Thick (upper epidermis)

Qualitative

Protective adaptation

Evans (2009)

Powder Microscopy

Fibers, trichomes, starch grains

Qualitative

Useful for crude drug identification

Kokate et al. (2010)

Table 6: Quantitative and Qualitative Microscopic parameters

Quantitative leaf constants such as stomatal index, vein islet number, and vein termination number are compiled from available secondary data sources and require further experimental validation for standardization in Argyreia nervosa

PHYSICOCHEMICAL ESTIMATION

Several pharmacognostic studies on Argyreia nervosa have employed physicochemical parameters to establish quality standards of plant materials, particularly roots and leaves, which are widely used in traditional medicine (Kokate et al., 2010; Mukherjee, 2019).

  • Ash Values

Ash values measure the total inorganic residue remaining after incineration and help identify contamination or adulteration. The parameters commonly assessed include:

  • Total ash, representing total mineral content,
  • Acid-insoluble ash, indicating siliceous impurities such as sand,
  • Water-soluble ash, representing soluble inorganic salts.
  • Extractive Values

Extractive values estimate the amount of active constituents extracted by solvents of varying polarity. Alcohol-soluble and water-soluble extractive values are commonly measured and provide insight into the presence of polar phytoconstituents such as phenolics, flavonoids, glycosides, and alkaloids (Evans, 2009).

  • Moisture Content (Loss on Drying)   

Loss on drying reflects moisture content present in plant material (WHO, 2011).

  • pH Determination

pH evaluation is particularly relevant for formulation development, especially topical applications.

  • Foreign Matter Determination

Foreign matter analysis ensures removal of extraneous materials such as soil, insects, or other plant contaminants before pharmaceutical processing. Proper cleaning and authentication reduce risk of adulteration (Evans, 2009).

S. No.

Ash type

Percentage of Ash

1

Total ash

4.3% w/w

2

Acid insoluble ash

1.6% w/w

3

Water soluble ash

3.94% w/w

Table 7: Ash value

S. No.

Solvent

Percentage of extractive

1

Petroleum ether

3.16% w/w

2

Chloroform

0.8% w/w

3

Ethyl acetate

1.4% w/w

4

Ethanol

0.2% w/w

5

Water

7.6% w/w

Table 8: Extractive value

Parameter

Typical Reported Range

Total ash

4–10 % w/w

Acid-insoluble ash

1–3 % w/w

Water-soluble ash

2–6 % w/w

Alcohol extractive value

7–16 % w/w

Water extractive value

10–22 % w/w

Loss on drying

5–11 % w/w

pH (1% solution)

5.5–7.5

Table 9: Summary of Physicochemical Parameter

PHYTOCHEMICAL SCREENING

Preliminary phytochemical screening provides qualitative information regarding the presence of major classes of bioactive compounds responsible for therapeutic effects. In Argyreia nervosa, different plant parts including roots, leaves, seeds, and stems have been subjected to phytochemical investigation, revealing the presence of diverse secondary metabolites contributing to its pharmacological activities. (Harborne, 1998).

Phytochemical Constituents

Test

Hexane Extract

Chloroform Extract

Methanol Extract

Aqueous Extract

Carbohydrates

Molisch’s test

+

 

Fehling’s test

+

 

Benedict’s test

+

 

Phloroglucinol test

Proteins

Biuret test

+

 

Millon’s test

+

 

Ninhydrin test

 

Xanthoprotein test

+

Steroids & Triterpenes

Liebermann–Burchard test

+

 

Salkowski test

+

 

Antimony trichloride test

 

Trichloroacetic acid test

Saponins

Foam test

+

 

Hemolysis test

+

Alkaloids

Dragendorff’s test

+

+

 

Mayer’s test

+

+

 

Wagner’s test

+

+

 

Hager’s test

+

+

 

Tannic acid test

+

+

Anthraquinone glycosides

Borntrager’s test

+

 

Modified Borntrager’s test

Cardiac glycosides

Keller–Killiani test

 

Legal test

Flavonoids

Lead acetate test

+

 

Ammonia test

+

 

Shinoda test

+

 

Vanillin HCl test

Lipids

Solubility test

+

 

Sudan IV test

+

 

Grease spot test

+

 

Emulsification test

+

Table 10: Preliminary Phytochemical screening (Kaur, et.al)

Phytochemical Constituents Reported in Argyreia nervosa:-

A. nervosa is phytochemically rich and comprises a diverse array of secondary metabolites, including alkaloids, flavonoids, phenolic compounds, glycosides, saponins, and terpenoids. Among these, ergoline alkaloids are the most extensively studied and pharmacologically significant constituents, particularly concentrated in the seeds (Ghosal et al., 1971; Chao & Der Marderosian, 1973).

Phytochemical investigations across different plant parts such as seeds, leaves, and roots indicate variation in chemical composition, suggesting a part-specific distribution of bioactive compounds, which contributes to the plant’s broad spectrum of pharmacological activities (Jaiswal et al., 2010).

Various studies report that hydroalcoholic and ethanolic extracts of A. nervosa show strong presence of phenolic compounds and flavonoids, along with alkaloids and tannins, which correlate with antioxidant, anti-inflammatory, antimicrobial, and neuroprotective activities observed in pharmacological studies (Jaiswal et al., 2015).

Seeds of the plant are particularly known for the presence of ergoline alkaloids, including lysergic acid derivatives, while roots and leaves predominantly contain flavonoids, phenolics, triterpenoids, and glycosidic constituents (Shukla et al., 1999).

Plant Part

Phytoconstituent

Chemical Class

Structure

Seeds

Ergine (Lysergic acid amide)

Ergoline alkaloid

 

 

Isoergine

Ergoline alkaloid

 

 

 

Lysergol

Ergoline alkaloid

 

 

Roots

Quercetin

Flavonoid

 

 

Kaempferol

Flavonoid

 

 

β-Sitosterol

Phytosterol

 

 

 

Friedelin

Triterpenoid

 

 

Leaves

Rutin

Flavonoid glycoside

 

 

Caffeic acid

Phenolic acid

 

 

Chlorogenic acid

Phenolic ester

 

 

Stem

Scopoletin

Coumarin derivative

 

 

Whole plant

Tannins (various)

Polyphenols

 

 

Table 11: Phytoconstituents and Structural Information

PHARMACOLOGICAL POTENTIAL

Pharmacological Activity

Plant Part / Extract

Experimental Model

Dose / Method

Key Findings

Reference

Immunomodulatory

Root, ethanolic extract

Mice; DTH & antibody response

50–200 mg/kg (oral)

Enhanced cellular & humoral immunity, increased WBC count, reversed cyclophosphamide-induced myelosuppression

Gokhale et al., 2003

Hepatoprotective & Antioxidant

Root, ethanolic & ethyl acetate

CClâ‚„-induced hepatotoxic rats

200–400 mg/kg

Reduced liver enzymes, improved antioxidant status, protected liver tissue

Habbu et al., 2008

Anti-inflammatory

Root alcoholic/methanolic extract

Carrageenan paw edema

50–200 mg/kg

Significant inhibition of edema and inflammation

Patel et al., 2012

Analgesic

Root methanolic extract

Writhing, hot plate, tail immersion

30–300 mg/kg

Reduced pain response and increased latency

Patel et al., 2012

Hypoglycemic / Antidiabetic

Stem methanolic extract

Alloxan-induced diabetic rats

250–750 mg/kg

Significant reduction in blood glucose levels

Dashora et al., 2005

Anticonvulsant

Root hydroalcoholic extract

PTZ & MES seizure models

200–400 mg/kg

Delayed seizure onset, reduced duration

Vyawahare et al., 2007

CNS Depressant

Root fractions

Pentobarbital sleep model

100–500 mg/kg

Increased sleep duration, reduced locomotion

Vyawahare et al., 2007

Antimicrobial

Leaf, root, seed extracts

In vitro microbial assays

Various

Active against Staphylococcus aureus & fungi

Habbu et al., 2009

Antiviral

Whole plant extract

CAM model (vaccinia virus)

In vitro

Exhibited interferon-like antiviral activity

Rao et al., 2004

Antiulcer

Flower ethanolic extract

Ethanol, aspirin, pylorus ligation

100–200 mg/kg

Reduced ulcer index, protected gastric mucosa

Galani & Patel, 2010

Wound Healing

Leaf extracts

Excision wound model

Topical

Faster wound contraction, ↑ collagen synthesis

Galani & Patel, 2010

Aphrodisiac

Root extract

Sexual behavior study (male mice)

~200 mg/kg

Increased mating behavior & fertility

Jaiswal et al., 2010

Nootropic

Root extract

Maze & avoidance models

100–400 mg/kg

Improved memory and reversed amnesia

Vyawahare et al., 2007

Table 12: Pharmacological Activities Reported for Argyreia nervosa

INTEGRATED MECHANISTIC PATHWAY

Phytochemicals → Molecular Targets → Biological Effects → Pharmacological Outcome

  • Alkaloids → Serotonin receptors → CNS modulation → Nootropic / CNS effects
  • Flavonoids → ROS scavenging → Reduced oxidative stress → Antioxidant / hepatoprotective
  • Saponins → Immune activation → Cytokine modulation → Immunomodulatory
  • Phenolics → COX inhibition → Reduced inflammation → Anti-inflammatory

EXTRACTION

Extraction of bioactive constituents from medicinal plants represents a critical step influencing phytochemical yield, reproducibility, and subsequent pharmacological evaluation. In the case of Argyreia nervosa, multiple extraction approaches have been reported depending on plant part, solvent polarity, and target compound classes. For a review article, emphasis is placed not on procedural detail but on comparative evaluation of extraction methodologies documented in the literature.

Plant parts such as roots, leaves, stems, and seeds are generally cleaned, shade-dried to preserve thermolabile compounds, and pulverized into coarse powder before extraction. Particle size reduction increases surface area, thereby enhancing solvent penetration and extraction efficiency (Mukherjee, 2019).

Influence of Solvent Selection

Solvent polarity plays a decisive role in phytoconstituent recovery. Extraction studies on A. nervosa commonly employ solvents in order of increasing polarity:

  • Non-polar solvents (petroleum ether, hexane) for lipids, waxes, and sterols,
  • Moderately polar solvents (chloroform, ethyl acetate) for terpenoids and some alkaloids,
  • Polar solvents (ethanol, methanol, hydroalcoholic mixtures, water) for flavonoids, phenolics, tannins, glycosides, and alkaloids.

Hydroalcoholic solvents are frequently preferred because they simultaneously extract a broad spectrum of phytochemicals while maintaining pharmaceutical acceptability (Azmir et al., 2013).

Maceration with Aqueous and Organic Solvents

One of the earliest reported extraction protocols for A. nervosa was described in a pharmacognosy study where leaf powder was subjected to simple maceration with different solvents. In this study, coarsely powdered leaves were extracted using distilled water, alcohol, hexane, and methanol sequentially by maceration until solvent became colorless, followed by filtration and concentration under reduced pressure using a rotary evaporator. This approach allowed recovery of broad classes of phytochemicals and supported downstream phytochemical profiling and biological evaluation. (Shreedhara et al., 2009).

This method highlights how maceration remains a practical approach for initial extraction, especially for polar (aqueous, hydroalcoholic) and non-polar (hexane) compounds. Nutraceutical and quality control studies often apply maceration when heat-sensitive constituents such as phenolics and flavonoids are of interest. (Mukherjee, 2019).

Soxhlet Extraction with Hydroalcoholic Solvent

A frequently encountered extraction technique in A. nervosa research is Soxhlet extraction using hydroalcoholic or ethanolic solvents. For example, in the investigation of analgesic and anti-inflammatory activity of A. speciosa roots, powdered root material was extracted using 70% ethanol in a Soxhlet apparatus, continuing the cycle until exhaustive extraction was achieved. The solvent was then removed under reduced pressure, yielding concentrated extract for screening. (Bachhav et al., 2009).

Soxhlet extraction is widely used in plant research because:

  • It ensures continuous solvent percolation, improving yield.
  • The use of a hydroalcoholic solvent maximizes extraction of both polar and semi-polar compounds including flavonoids, phenolics, and alkaloids.
  • It provides reproducibility, which is important when comparing pharmacological activities across studies.

However, prolonged heating in Soxhlet may degrade highly labile phytochemicals, so its use is best suited for thermally stable classes or when exhaustive extraction is prioritized.

Aqueous Extraction for Biological Activity Studies

Some pharmacological studies introduce pure aqueous extraction reflecting traditional preparation methods. For example, an antioxidant activity investigation of an aqueous root extract of A. nervosa employed simple immersion of powdered roots in water, followed by filtration and concentration. This yielded an extract evaluated for free radical scavenging using in vitro methods. (Shreedhara et al., 2009).

Aqueous extraction is often used when the research aim is to:

  • Mimic traditional Ayurvedic or folk preparations;
  • Focus on highly polar constituents;
  • Evaluate extracts with high safety profiles suitable for oral or topical applications. (Khandelwal, 2008).

Solvent-Based Fractionation (Organic Solvent Series)

Although less commonly reported specifically for A. nervosa, general pharmacognostic and phytochemical studies often use serial solvent extraction, where powdered material is successively treated with solvents of increasing polarity (e.g., hexane → chloroform → ethyl acetate → methanol → water). This approach helps in fractionating compounds by polarity and enhances identification of phytochemicals associated with distinct pharmacological effects (e.g., alkaloids in organic fractions, flavonoids in polar fractions) as seen in related species studies. (Khandelwal, 2008; Mukherjee, 2019).

Method

Principle

Strengths

Limitations

Maceration

Soaking in solvent at room temperature

Simple, preserves heat-labile compounds

Lower efficiency, longer time

Soxhlet Extraction

Continuous solvent cycling

High yield, reproducible

Heat exposure may degrade sensitive compounds

Aqueous Extraction

Traditional water solubilization

Reflects folk use, safe extracts

May miss non-polar constituents

Solvent Fractionation

Stepwise polarity extraction

Profiles multiple chemical classes

More time and solvent required

Table 13: Comparative consideration of extraction procedure

QUANTITATIVE ESTIMATION

Quantitative estimation of phytochemical constituents is a critical component of pharmacognostic standardization and quality assessment of medicinal plants. In Argyreia nervosa, estimation of phenolics, flavonoids, alkaloids, and tannins has been reported in several phytochemical investigations employing spectrophotometric and gravimetric analytical methods. Such quantification assists in correlating phytochemical composition with antioxidant, anti-inflammatory, and wound healing activities reported for the plant. Hydroalcoholic and ethanolic extracts are most commonly evaluated due to their efficiency in extracting broad classes of bioactive compounds (Harborne, 1998; Trease & Evans, 2009).

Estimation of Total Phenolic Content (TPC)

Total phenolic content in A. nervosa extracts is commonly determined using the Folin–Ciocalteu colorimetric method, which is widely accepted for quantification of phenolic compounds in medicinal plants. Studies evaluating antioxidant potential of A. nervosa extracts have reported considerable phenolic contributions supporting pharmacological activity (Singleton et al., 1999; Shreedhara et al., 2009).

Estimation of Total Flavonoid Content (TFC)

Flavonoid quantification in A. nervosa extracts is frequently performed using the aluminum chloride colorimetric assay. Investigations on hydroalcoholic extracts of A. nervosa demonstrate significant flavonoid presence, which is associated with antioxidant and anti-inflammatory activities (Chang et al., 2002; Harborne, 1998).

Estimation of Total Alkaloid Content

Total alkaloid content in A. nervosa is generally estimated using classical acid–base extraction followed by gravimetric determination. The presence of ergoline and related alkaloids in A. nervosa makes such estimation important for pharmacognostic standardization (Trease & Evans, 2009; Siddiqui & Ali, 1997).

Estimation of Total Tannin Content

Tannin quantification in medicinal plants including A. nervosa extracts is often carried out using Folin–Denis or modified Folin–Ciocalteu assays. Reported tannin presence supports the plant’s traditional applications in wound healing and astringent preparations (Trease & Evans, 2009; Harborne, 1998)

Extract Type

TPC (mg GAE/g)

TFC (mg QE/g)

TTC (mg CE/g)

Trend/ Observation

Reference

Petroleum Ether Extract

5 – 30

5 – 25

10 – 40

Lowest due to non-polar nature

Singh et al., 2019

Ethanolic Extract

50 – 180

40 – 120

20 – 80

High phenolics & flavonoids

Sahu et al., 2020; Patel et al., 2018

Hydroalcoholic Extract

60 – 150

50 – 140

25 – 90

Best extraction efficiency

Sharma et al., 2019; Jaiswal et al., 2017

Aqueous Extract

20 – 90

15 – 80

10 – 50

Traditional extraction

Gupta et al., 2016

Table 14: Compilation of quantitative estimation

DEVELOPED FORMULATIONS of A.nervosa

Formulation Type

Dosage Form

Plant Part

Application

Key Outcome

Reference

Ointment

15% extract ointment

Leaf

Wound healing

Faster contraction, epithelization

Singhal et al., 2011

Topical extract

Vehicle-based topical

Leaf

Anti-inflammatory, wound healing

Improved healing vs oral route

Singhal et al., 2011

Nanoparticle formulation

Silver nanoparticles

Leaf

Antioxidant, anti-inflammatory

Enhanced bioactivity

Krishnamoorthy, K. et.al

Extract formulations

Ethanolic/methanolic

Root/

leaf

Multiple pharmacological uses

Standard experimental model

Multiple studies

Gel / Emulgel (potential)

Not fully developed

Wound healing

High future scope

Literature gap

Table 15: Different Developed Formulation of A.nervosa

Despite promising wound healing outcomes using ointment formulations, advanced topical delivery systems such as gels, emulgels, and nanoformulations remain underexplored for Argyreia nervosa, representing a significant opportunity for future pharmaceutical development.

TOXICOLOGY AND SAFETY PROFILE OF Argyreia Nervosa

Toxicological evaluation of Argyreia nervosa indicates that although the plant exhibits multiple therapeutic properties, its safety profile requires careful consideration due to the presence of ergoline alkaloids, which are known to exert central nervous system effects.

Toxicity Type

Experimental Evidence

Dose Range

Observed Effects

Inference

Reference

Acute Toxicity

Rodent studies (oral)

Up to 2000 mg/kg

No mortality, no behavioral abnormalities

Considered relatively safe at therapeutic doses

Habbu et al., 2008

Subacute Toxicity

14–28 day studies

100–400 mg/kg

No significant change in organ weight, hematology

Safe under controlled dosing

Vyawahare et al., 2007

Neurotoxicity

CNS activity studies

Variable

CNS depression, behavioral changes

Due to ergoline alkaloids

Halpern, 2004

Psychoactive Effects

Seed alkaloid studies

Not standardized

Hallucinogenic effects (LSA)

Requires caution in use

Halpern, 2004

Reproductive Toxicity

Limited data

Not well established

Major research gap

Jaiswal et al., 2010

Table 16: Toxicological Profile of A.nervosa

Although preclinical studies suggest a relatively safe profile at therapeutic doses, the presence of ergoline alkaloids necessitates cautious use, particularly concerning neuropharmacological effects and long-term safety.

HERB–DRUG INTERACTIONS

Due to its CNS-active constituents, Argyreia nervosa has a significant potential for herb–drug interactions, particularly with neuroactive medications.

Drug Class

Interaction Type

Mechanism

Possible Outcome

Clinical Significance

Reference

Antidepressants (SSRIs)

Synergistic

Serotonergic pathway modulation

Risk of serotonin syndrome

High caution required

Halpern, 2004

CNS Depressants

Additive

CNS inhibition

Excess sedation

Avoid co-administration

Vyawahare et al., 2007

Antipsychotics

Antagonistic/Synergistic

Dopamine/serotonin interaction

Altered drug response

Monitor closely

Halpern, 2004

Immunosuppressants

Opposing effect

Immune stimulation

Reduced drug efficacy

Important in therapy

Gokhale et al., 2003

Table 17: Herb Drug Interactions of A.nervosa

STRUCTURE–ACTIVITY RELATIONSHIP (SAR) TABLE

Phytoconstituent

Structural Feature

Target Site

Mechanism

Pharmacological Effect

Reference

Ergoline Alkaloids

Tetracyclic ergoline nucleus

5-HTâ‚‚A receptors

Partial agonist

CNS activity, hallucinogenic

Halpern, 2004

Flavonoids

Phenolic OH groups

Free radicals

ROS scavenging

Antioxidant

Rice-Evans et al., 1996

Phenolic Compounds

Aromatic rings + OH

Oxidative pathways

Electron donation

Anti-inflammatory

Habbu et al., 2008

Saponins

Glycosidic structure

Cell membrane

Immune activation

Immunomodulatory

Gokhale et al., 2003

Table 18: SAR of Major Phytoconstituents

DISCUSSION

Argyreia nervosa (Burm. f.) Bojer represents a valuable medicinal plant whose traditional applications are increasingly supported by modern scientific evidence. The diverse pharmacological activities reported for the plant, including antioxidant, anti-inflammatory, hepatoprotective, immunomodulatory, neuroprotective, antimicrobial, and wound healing effects, can largely be attributed to its rich phytochemical profile comprising ergoline alkaloids, flavonoids, phenolic compounds, tannins, and triterpenoids. Notably, the correlation between ethnomedicinal claims and experimental findings highlights the therapeutic relevance of the species. Furthermore, pharmacognostic and physicochemical parameters provide a basis for quality control and standardization. Although preliminary formulation studies have demonstrated promising pharmaceutical applications, particularly in topical drug delivery, the majority of available evidence remains confined to preclinical investigations. Therefore, further studies focusing on standardization, safety assessment, mechanistic elucidation, and clinical validation are warranted to facilitate its successful translation into evidence-based therapeutics.

CONCLUSION

Argyreia nervosa is a phytochemically rich and pharmacologically versatile medicinal climber with significant ethnomedicinal importance. The available literature demonstrates that its traditional uses are supported by a growing body of scientific evidence, particularly in relation to antioxidant, anti-inflammatory, neuroprotective, hepatoprotective, and wound healing activities. Despite these promising findings, comprehensive clinical studies and standardized formulations remain limited. Future research aimed at bioactive compound characterization, quality standardization, advanced formulation development, and clinical evaluation will be crucial for realizing the full therapeutic potential of this traditionally valued medicinal plant.

ACKNOWLEDGEMENT

I express sincere gratitude to the Department of Pharmacognosy, Priyadarshini J.L. College of Pharmacy, Nagpur, Maharashtra, for providing the necessary academic resources and support for the preparation of this review article. I also acknowledge the valuable contributions of researchers and scholars whose published work has significantly contributed to the understanding of Argyreia nervosa and served as an important foundation for this review.

REFERENCES

  1. Ahlawat S, et al.: Pharmacognostical evaluation of Argyreia speciosa (Burm. f.) Bojer. Pharmacognosy Magazine (2009); 1(3): 227-232.
  2. Aiyer KN and Kolammal M: Pharmacognosy of Ayurvedic drugs: Kerala. Department of Pharmacognosy, University of Kerala, Vol. 1, 1964: 61-65.
  3. Ali SA, Hamed MA, El-Rigal NS, Shabana MH and Kassem MES: Chemical constituents of Argyreia speciosa Fam. Convolvulaceae and its role against hyperglycemia. Journal of Applied Pharmaceutical Science (2011); 1(6): 76-84.
  4. Ashutosh M, Kumar AA and Ranjan PA: A literature review on Argyreia nervosa (Burm. f.) Bojer. International Journal of Research in Ayurveda and Pharmacy (2011); 2: 1501-1504.
  5. Azmir J, Zaidul ISM, Rahman MM, Sharif KM, Mohamed A, Sahena F, Jahurul MHA, Ghafoor K, Norulaini NAN and Omar AKM: Techniques for extraction of bioactive compounds from plant materials: A review. Journal of Food Engineering (2013); 117(4): 426-436.
  6. Bachhav RS, Gulecha VS and Upasani CD: Analgesic and anti-inflammatory activity of Argyreia speciosa root. Indian Journal of Pharmacology (2009); 41(4): 158-161.
  7. Borsutzky M, Passie T, Paetzold W, Emrich HM and Schneider U: Hawaiianische Holzrose: (Psycho-)pharmakologische Wirkungen der Samen der Argyreia nervosa. Eine fallbezogene Darstellung. Der Nervenarzt (2002); 73(9): 892-896.
  8. Chang C, Yang M, Wen H and Chern J: Estimation of total flavonoid content by colorimetric methods. Journal of Food and Drug Analysis (2002); 10(3): 178-182.
  9. Chao JM and Der Marderosian AH: Identification of ergoline alkaloids in the genus Argyreia and related genera and their chemotaxonomic implications in the Convolvulaceae. Phytochemistry (1973); 12(12): 2435-2440.
  10. Council of Scientific and Industrial Research: The Wealth of India: Raw Materials. Publication and Information Directorate, CSIR, 1985.
  11. Dashora N, Sodde V and Prabhu K: Antidiabetic activity of Argyreia speciosa. Journal of Natural Remedies (2005); 5(2): 145-148.
  12. Ekade PP and Manik SR: Profiling of chemical constituents in Argyreia nervosa fruits using modern techniques. Introduction (1985): 235-240.
  13. Evans WC: Trease and Evans Pharmacognosy. Saunders Elsevier, Edition 16, 2009.
  14. Fabricant DS and Farnsworth NR: The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives (2001); 109(Suppl.1): 69-75.
  15. Galani VJ and Patel BG: Antiulcer and wound healing activity of Argyreia speciosa. Journal of Natural Medicines (2010); 64(1): 53-59.
  16. Gamble JS: Flora of Madras. Botanical Survey of India, Vol. 2, 1956: 556.
  17. Girach RD, Aminuddin and Ahmad M: Medical ethnobotany of Sundargarh, Orissa, India. Pharmaceutical Biology (1998); 36: 20-24.
  18. Gokhale AB, Damre AS and Saraf MN: Investigations into the immunomodulatory activity of Argyreia speciosa. Journal of Ethnopharmacology (2003); 84(1): 109-114.
  19. Guhabakshi DN, Sensarma P and Pal DC: A lexicon of medicinal plants in India. Vol. 1, New Delhi, 1999: 180-181.
  20. Habbu PV, Mahadevan KM, Joshi H and Das SK: Antimicrobial activity of Argyreia speciosa. African Journal of Biotechnology (2009); 8(4): 667-671.
  21. Habbu PV, Shastry RA, Mahadevan KM, Joshi H and Das SK: Hepatoprotective activity of Argyreia speciosa. Indian Journal of Experimental Biology (2008); 46: 591-597.
  22. Harborne JB: Phytochemical methods: A guide to modern techniques of plant analysis. Chapman & Hall, Edition 3, 1998.
  23. Jaiswal A, Bhattacharya SK and Acharya SB: Aphrodisiac activity of Argyreia speciosa. Journal of Ethnopharmacology (2010); 131(2): 409-413.
  24. Jaiswal BS and Tailang M: Phytochemistry and pharmacological profile of traditionally used medicinal plant Argyreia speciosa (Syn. A. nervosa). Journal of Drug Delivery and Therapeutics (2019); 9(5): 1937-1944.
  25. Jaiswal SK, Rao CV and Dubey MK: Effect of the bioactive fraction of Argyreia speciosa leaves against gastric ulcer and antioxidant defence system in rats. Current Traditional Medicine (2015); 1(1): 62-72.
  26. Joseph A, Mathew S, Skaria BP and Sheeja EC: Medicinal uses and biological activities of Argyreia speciosa Sweet (Hawaiian baby woodrose): An overview. Indian Journal of Natural Products and Resources (2011); 2(3): 286-291.
  27. Kaur J, Singh R, Malik M, Singh B and Kaur S: Pharmacognostic investigations and phytochemical screening of Argyreia speciosa Linn. International Journal of Green Pharmacy (2018); 12(2).
  28. Khare CP: Indian medicinal plants: An illustrated dictionary. Springer, 2007.
  29. Kirtikar KR and Basu BD: Indian medicinal plants. International Book Distributors, Vol. 3, 2005.
  30. Kirtikar KR and Basu BD: Indian medicinal plants. Lalit Mohan Basu Publication, Edition 2, Vol. 3, 1981: 1707-1708.
  31. Kokate CK, Purohit AP and Gokhale SB: Pharmacognosy. Nirali Prakashan, Edition 47, 2010.
  32. Krishnaveni A and Thaakur SR: Pharmacognostical and preliminary phytochemical studies of Argyreia nervosa Burm. Ethnobotanical Leaflets (2009); 13: 293-300.
  33. Modi AJ, Khadabadi SS, Deokate UA, Farooqui IA and Deore SL: Pharmacognosy and pharmacological studies. Pharmacognosy and Pharmacological Studies (2010); 2: 34-42.
  34. Mukherjee PK: Quality control and evaluation of herbal drugs: Evaluating natural products and traditional medicine. Elsevier, Edition 2, 2019.
  35. Nadkarni AK: Indian Materia Medica. Popular Prakashan Pvt. Ltd., 2007.
  36. Newman DJ and Cragg GM: Natural products as sources of new drugs over the last 25 years. Journal of Natural Products (2016); 79(3): 629-661.
  37. Patel DK, Kumar R and Laloo D: Phytochemical investigation of Argyreia nervosa: Isolation of ergometrine and isoquercetin. International Journal of Pharmaceutical Investigation (2012); 2(3): 150-154.
  38. Patel SB, Santani DD and Shah MB: Anti-inflammatory and analgesic activity of Argyreia speciosa. International Journal of Pharmaceutical Sciences (2012); 4(3): 321-325.
  39. Patwardhan B, Warude D, Pushpangadan P and Bhatt N: Ayurveda and traditional Chinese medicine: A comparative overview. Evidence-Based Complementary and Alternative Medicine (2005); 2(4): 465-473.
  40. Pawar RS, et al.: Quantification of scopoletin from the roots of Argyreia speciosa (Linn. F.) Sweet using HPLC through the concept of Design of Experiment. Journal of AOAC International (2021); 104(4): 1167-1173.
  41. Rahman A, Ali M and Khan NZ: Argyroside from Argyreia nervosa seeds. Pharmazie (2003); 58(1): 60-62.
  42. Rao GMM, et al.: Antiviral activity of Indian medicinal plants. Fitoterapia (2004); 75(1): 22-33.
  43. Saxena HO and Brahmam M: Flora of Orissa. Regional Research Laboratory and Forest Development Corporation of Orissa, Bhubaneswar, Vol. I, 1994.
  44. Sharma PC, Yelne MB and Dennis TJ: Database on medicinal plants used in Ayurveda. Documentation and Publication Division, Vol. 2, 2001: 550-553.
  45. Sharma RK and Dash B (Trans.): Charaka Samhita. Chowkhamba Sanskrit Series Office, 2008.
  46. Shreedhara CS, Aswatha Ram HN, Zanwar SB and Falguni GP: Free radical scavenging activity of aqueous root extract of Argyreia nervosa. Journal of Natural Remedies (2009); 9(2): 216-223.
  47. Shukla YN, Srivastava A, Kumar S and Kumar S: Phytotoxic and antimicrobial constituents of Argyreia speciosa and Oenothera biennis. Journal of Ethnopharmacology (1999); 67(2): 241-245.
  48. Siddiqui AA and Ali M: Practical Pharmaceutical Chemistry. CBS Publishers and Distributors, 1997.
  49. Singh B: Pharmacognostic investigations and phytochemical screening of Argyreia speciosa Linn. International Journal of Green Pharmacy (2018); 12(2).
  50. Singhal A, Gupta H and Bhati V: Wound healing activity of Argyreia nervosa leaves extract. International Journal of Applied and Basic Medical Research (2011); 1(1): 36-39.
  51. Singleton VL, Orthofer R and Lamuela-Raventós RM: Analysis of total phenols using Folin–Ciocalteu reagent. Methods in Enzymology (1999); 299: 152-178.
  52. Subramoniam A, Madhavachandran V, Ravi K and Anuja VS: Aphrodisiac property of the elephant creeper Argyreia nervosa. Journal of Endocrinology and Reproduction (2007); 11(2): 82-85.
  53. Sukumar S, Nartunai G, Kumar KNS, Sujith T, Shakila R and Ilavarasan R: Pharmacognostical studies on seeds of Argyreia nervosa (Burm. f.) Boj. and its market adulteration Thespesia populnea (L.) Sol. ex Corrêa. Pharmacognosy Research (2024); 16(3): 495-507.
  54. Traiperm P, Chow J, Nopun P, Staples G and Swangpol SC: Identification among morphologically similar Argyreia species based on leaf anatomy and phenetic analyses. Botanical Studies (2017); 58(1): 25.
  55. Vyawahare NS, et al.: CNS activity of Argyreia speciosa. Pharmacology Biochemistry and Behavior (2007); 86(1): 161-167.
  56. World Health Organization: Quality control methods for herbal materials. WHO Press, Geneva, Updated Edition, 2011.
  57. World Health Organization: Quality control methods for medicinal plant materials. World Health Organization, Geneva, 1998.
  58. World Health Organization: WHO traditional medicine strategy 2014–2023. World Health Organization, Geneva, 2013.

Reference

  1. Ahlawat S, et al.: Pharmacognostical evaluation of Argyreia speciosa (Burm. f.) Bojer. Pharmacognosy Magazine (2009); 1(3): 227-232.
  2. Aiyer KN and Kolammal M: Pharmacognosy of Ayurvedic drugs: Kerala. Department of Pharmacognosy, University of Kerala, Vol. 1, 1964: 61-65.
  3. Ali SA, Hamed MA, El-Rigal NS, Shabana MH and Kassem MES: Chemical constituents of Argyreia speciosa Fam. Convolvulaceae and its role against hyperglycemia. Journal of Applied Pharmaceutical Science (2011); 1(6): 76-84.
  4. Ashutosh M, Kumar AA and Ranjan PA: A literature review on Argyreia nervosa (Burm. f.) Bojer. International Journal of Research in Ayurveda and Pharmacy (2011); 2: 1501-1504.
  5. Azmir J, Zaidul ISM, Rahman MM, Sharif KM, Mohamed A, Sahena F, Jahurul MHA, Ghafoor K, Norulaini NAN and Omar AKM: Techniques for extraction of bioactive compounds from plant materials: A review. Journal of Food Engineering (2013); 117(4): 426-436.
  6. Bachhav RS, Gulecha VS and Upasani CD: Analgesic and anti-inflammatory activity of Argyreia speciosa root. Indian Journal of Pharmacology (2009); 41(4): 158-161.
  7. Borsutzky M, Passie T, Paetzold W, Emrich HM and Schneider U: Hawaiianische Holzrose: (Psycho-)pharmakologische Wirkungen der Samen der Argyreia nervosa. Eine fallbezogene Darstellung. Der Nervenarzt (2002); 73(9): 892-896.
  8. Chang C, Yang M, Wen H and Chern J: Estimation of total flavonoid content by colorimetric methods. Journal of Food and Drug Analysis (2002); 10(3): 178-182.
  9. Chao JM and Der Marderosian AH: Identification of ergoline alkaloids in the genus Argyreia and related genera and their chemotaxonomic implications in the Convolvulaceae. Phytochemistry (1973); 12(12): 2435-2440.
  10. Council of Scientific and Industrial Research: The Wealth of India: Raw Materials. Publication and Information Directorate, CSIR, 1985.
  11. Dashora N, Sodde V and Prabhu K: Antidiabetic activity of Argyreia speciosa. Journal of Natural Remedies (2005); 5(2): 145-148.
  12. Ekade PP and Manik SR: Profiling of chemical constituents in Argyreia nervosa fruits using modern techniques. Introduction (1985): 235-240.
  13. Evans WC: Trease and Evans Pharmacognosy. Saunders Elsevier, Edition 16, 2009.
  14. Fabricant DS and Farnsworth NR: The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives (2001); 109(Suppl.1): 69-75.
  15. Galani VJ and Patel BG: Antiulcer and wound healing activity of Argyreia speciosa. Journal of Natural Medicines (2010); 64(1): 53-59.
  16. Gamble JS: Flora of Madras. Botanical Survey of India, Vol. 2, 1956: 556.
  17. Girach RD, Aminuddin and Ahmad M: Medical ethnobotany of Sundargarh, Orissa, India. Pharmaceutical Biology (1998); 36: 20-24.
  18. Gokhale AB, Damre AS and Saraf MN: Investigations into the immunomodulatory activity of Argyreia speciosa. Journal of Ethnopharmacology (2003); 84(1): 109-114.
  19. Guhabakshi DN, Sensarma P and Pal DC: A lexicon of medicinal plants in India. Vol. 1, New Delhi, 1999: 180-181.
  20. Habbu PV, Mahadevan KM, Joshi H and Das SK: Antimicrobial activity of Argyreia speciosa. African Journal of Biotechnology (2009); 8(4): 667-671.
  21. Habbu PV, Shastry RA, Mahadevan KM, Joshi H and Das SK: Hepatoprotective activity of Argyreia speciosa. Indian Journal of Experimental Biology (2008); 46: 591-597.
  22. Harborne JB: Phytochemical methods: A guide to modern techniques of plant analysis. Chapman & Hall, Edition 3, 1998.
  23. Jaiswal A, Bhattacharya SK and Acharya SB: Aphrodisiac activity of Argyreia speciosa. Journal of Ethnopharmacology (2010); 131(2): 409-413.
  24. Jaiswal BS and Tailang M: Phytochemistry and pharmacological profile of traditionally used medicinal plant Argyreia speciosa (Syn. A. nervosa). Journal of Drug Delivery and Therapeutics (2019); 9(5): 1937-1944.
  25. Jaiswal SK, Rao CV and Dubey MK: Effect of the bioactive fraction of Argyreia speciosa leaves against gastric ulcer and antioxidant defence system in rats. Current Traditional Medicine (2015); 1(1): 62-72.
  26. Joseph A, Mathew S, Skaria BP and Sheeja EC: Medicinal uses and biological activities of Argyreia speciosa Sweet (Hawaiian baby woodrose): An overview. Indian Journal of Natural Products and Resources (2011); 2(3): 286-291.
  27. Kaur J, Singh R, Malik M, Singh B and Kaur S: Pharmacognostic investigations and phytochemical screening of Argyreia speciosa Linn. International Journal of Green Pharmacy (2018); 12(2).
  28. Khare CP: Indian medicinal plants: An illustrated dictionary. Springer, 2007.
  29. Kirtikar KR and Basu BD: Indian medicinal plants. International Book Distributors, Vol. 3, 2005.
  30. Kirtikar KR and Basu BD: Indian medicinal plants. Lalit Mohan Basu Publication, Edition 2, Vol. 3, 1981: 1707-1708.
  31. Kokate CK, Purohit AP and Gokhale SB: Pharmacognosy. Nirali Prakashan, Edition 47, 2010.
  32. Krishnaveni A and Thaakur SR: Pharmacognostical and preliminary phytochemical studies of Argyreia nervosa Burm. Ethnobotanical Leaflets (2009); 13: 293-300.
  33. Modi AJ, Khadabadi SS, Deokate UA, Farooqui IA and Deore SL: Pharmacognosy and pharmacological studies. Pharmacognosy and Pharmacological Studies (2010); 2: 34-42.
  34. Mukherjee PK: Quality control and evaluation of herbal drugs: Evaluating natural products and traditional medicine. Elsevier, Edition 2, 2019.
  35. Nadkarni AK: Indian Materia Medica. Popular Prakashan Pvt. Ltd., 2007.
  36. Newman DJ and Cragg GM: Natural products as sources of new drugs over the last 25 years. Journal of Natural Products (2016); 79(3): 629-661.
  37. Patel DK, Kumar R and Laloo D: Phytochemical investigation of Argyreia nervosa: Isolation of ergometrine and isoquercetin. International Journal of Pharmaceutical Investigation (2012); 2(3): 150-154.
  38. Patel SB, Santani DD and Shah MB: Anti-inflammatory and analgesic activity of Argyreia speciosa. International Journal of Pharmaceutical Sciences (2012); 4(3): 321-325.
  39. Patwardhan B, Warude D, Pushpangadan P and Bhatt N: Ayurveda and traditional Chinese medicine: A comparative overview. Evidence-Based Complementary and Alternative Medicine (2005); 2(4): 465-473.
  40. Pawar RS, et al.: Quantification of scopoletin from the roots of Argyreia speciosa (Linn. F.) Sweet using HPLC through the concept of Design of Experiment. Journal of AOAC International (2021); 104(4): 1167-1173.
  41. Rahman A, Ali M and Khan NZ: Argyroside from Argyreia nervosa seeds. Pharmazie (2003); 58(1): 60-62.
  42. Rao GMM, et al.: Antiviral activity of Indian medicinal plants. Fitoterapia (2004); 75(1): 22-33.
  43. Saxena HO and Brahmam M: Flora of Orissa. Regional Research Laboratory and Forest Development Corporation of Orissa, Bhubaneswar, Vol. I, 1994.
  44. Sharma PC, Yelne MB and Dennis TJ: Database on medicinal plants used in Ayurveda. Documentation and Publication Division, Vol. 2, 2001: 550-553.
  45. Sharma RK and Dash B (Trans.): Charaka Samhita. Chowkhamba Sanskrit Series Office, 2008.
  46. Shreedhara CS, Aswatha Ram HN, Zanwar SB and Falguni GP: Free radical scavenging activity of aqueous root extract of Argyreia nervosa. Journal of Natural Remedies (2009); 9(2): 216-223.
  47. Shukla YN, Srivastava A, Kumar S and Kumar S: Phytotoxic and antimicrobial constituents of Argyreia speciosa and Oenothera biennis. Journal of Ethnopharmacology (1999); 67(2): 241-245.
  48. Siddiqui AA and Ali M: Practical Pharmaceutical Chemistry. CBS Publishers and Distributors, 1997.
  49. Singh B: Pharmacognostic investigations and phytochemical screening of Argyreia speciosa Linn. International Journal of Green Pharmacy (2018); 12(2).
  50. Singhal A, Gupta H and Bhati V: Wound healing activity of Argyreia nervosa leaves extract. International Journal of Applied and Basic Medical Research (2011); 1(1): 36-39.
  51. Singleton VL, Orthofer R and Lamuela-Raventós RM: Analysis of total phenols using Folin–Ciocalteu reagent. Methods in Enzymology (1999); 299: 152-178.
  52. Subramoniam A, Madhavachandran V, Ravi K and Anuja VS: Aphrodisiac property of the elephant creeper Argyreia nervosa. Journal of Endocrinology and Reproduction (2007); 11(2): 82-85.
  53. Sukumar S, Nartunai G, Kumar KNS, Sujith T, Shakila R and Ilavarasan R: Pharmacognostical studies on seeds of Argyreia nervosa (Burm. f.) Boj. and its market adulteration Thespesia populnea (L.) Sol. ex Corrêa. Pharmacognosy Research (2024); 16(3): 495-507.
  54. Traiperm P, Chow J, Nopun P, Staples G and Swangpol SC: Identification among morphologically similar Argyreia species based on leaf anatomy and phenetic analyses. Botanical Studies (2017); 58(1): 25.
  55. Vyawahare NS, et al.: CNS activity of Argyreia speciosa. Pharmacology Biochemistry and Behavior (2007); 86(1): 161-167.
  56. World Health Organization: Quality control methods for herbal materials. WHO Press, Geneva, Updated Edition, 2011.
  57. World Health Organization: Quality control methods for medicinal plant materials. World Health Organization, Geneva, 1998.
  58. World Health Organization: WHO traditional medicine strategy 2014–2023. World Health Organization, Geneva, 2013.

Photo
Samistha N. Shukla
Corresponding author

Department Of Pharmacognosy, Priyadarshini J.L. College of Pharmacy, Nagpur, Maharashtra

Photo
Shailiju Gurunani
Co-author

Department Of Pharmacognosy, Priyadarshini J.L. College of Pharmacy, Nagpur, Maharashtra

Samistha Shukla*, Shailiju Gurunani, Argyreia Nervosa (Burm. F.) Bojer: Rediscovering A Traditional Healer Through The Prism of Modern Science—From Ethnomedicinal Wisdom to Evidence-Based Therapeutics, Int. J. Sci. R. Tech., 2026, 3 (6), 1800-1822. https://doi.org/10.5281/zenodo.21068437

More related articles
Traditional Uses Vs Scientific Evidence: A Critica...
Dixa Baudh, Purnima Tiwari, Poonam Yadav, Umesh Pratap Singh...
Modern Concepts Of Integrating Artificial Intellig...
Zeeshan Afsar, Babu Ganesan, Rajendra Prasad MR, Manjunatha M, Sh...
Ethnomedicinal Plants Used in Gujarat For the Trea...
Hitesh Kumarkhaniya, Bharat Maitreya, Jagruti Nandaniya...
Related Articles
Turmeric in Traditional and Modern Medicine: Comparative Analysis...
Rahinj Sangram, Kuthval Rupali, Rasal Vaishnavi, Mate Akshada, Madhvi Modhale...
The Cultural Significance of Medicinal Plants in Literature and Traditional Medi...
Arnab Roy, Ayesha Memon, Navneet Kumar , Akash Bhattacharjee , Ritesh Kumar, Aniruddha Basak, Anura...
Analyze the Impact of Fintech on Traditional Banking...
Dr. R. Chandhrasekaran , Mathumitha S....
Traditional Uses Vs Scientific Evidence: A Critical Review Of Hibiscus Flower In...
Dixa Baudh, Purnima Tiwari, Poonam Yadav, Umesh Pratap Singh...
More related articles
Traditional Uses Vs Scientific Evidence: A Critical Review Of Hibiscus Flower In...
Dixa Baudh, Purnima Tiwari, Poonam Yadav, Umesh Pratap Singh...
Modern Concepts Of Integrating Artificial Intelligence With Traditional And Herb...
Zeeshan Afsar, Babu Ganesan, Rajendra Prasad MR, Manjunatha M, Shantiya K, Vimal KR, Nethaji R...
Ethnomedicinal Plants Used in Gujarat For the Treatment of Various Diseases...
Hitesh Kumarkhaniya, Bharat Maitreya, Jagruti Nandaniya...
Traditional Uses Vs Scientific Evidence: A Critical Review Of Hibiscus Flower In...
Dixa Baudh, Purnima Tiwari, Poonam Yadav, Umesh Pratap Singh...
Modern Concepts Of Integrating Artificial Intelligence With Traditional And Herb...
Zeeshan Afsar, Babu Ganesan, Rajendra Prasad MR, Manjunatha M, Shantiya K, Vimal KR, Nethaji R...
Ethnomedicinal Plants Used in Gujarat For the Treatment of Various Diseases...
Hitesh Kumarkhaniya, Bharat Maitreya, Jagruti Nandaniya...